Biogen to buy Nightstar for USD 800
Million
Biogen known for its efforts in treatments of multiple sclerosis and spinal muscular atrophy wound up the deal to buy Nightstar. The deal will let Biogen have access to two experimental gene therapies for blindness-causing diseases helping Biogen’s pipeline.
Pacira acquires Myoscience
Pacira Pharmaceuticals is going to acquire Myoscience, a medical device making company, as announced by the later in its press release for up to USD 220 Million. The deal is good news for patients and physicians who are looking for effective non-opioid treatment.
Horizon Pharma plc announces pricing
of public offering of its ordin...
